ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,505.00
      -0.71%
      US Tech 100
      19,000.00
      -0.94%
      Dow Jones
      40,287.53
      -0.93%
      Brent Oil
      81.875
      0.00%
      Bitcoin
      66,619.31
      -0.15%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Valerio Therapeutics (ALVIO) Quote

      Valerio Therapeutics

      Valerio Therapeutics (ALVIO)

      EU
      0.10
      0.001
      (1.01%)
      Closed July 20 11:30AM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      0.10
      Bid
      0.099
      Ask
      0.10
      Volume
      59,786
      0.10 Day's Range 0.1024
      0.09 52 Week Range 0.348
      Market Cap
      15.282M
      Previous Close
      0.099
      Open
      0.1008
      Last Trade
      2056
      @
      0.1
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      72,686
      Shares Outstanding
      154,364,273
      Dividend Yield
      -
      PE Ratio
      -9.71
      Earnings Per Share (EPS)
      -0.13
      Revenue
      4.45M
      Net Profit
      -20.34M

      About Valerio Therapeutics

      Sector
      Medicinal Chems,botanicl Pds
      Industry
      Medicinal Chems,botanicl Pds
      Website
      www.onxeo.com
      Headquarters
      Paris, Paris, Fra
      Founded
      1970
      Valerio Therapeutics is listed in the Medicinal Chems,botanicl Pds sector of the Euronext with ticker ALVIO. The last closing price for Valerio Therapeutics was 0.10 €. Over the last year, Valerio Therapeutics shares have traded in a share price range of 0.09 € to 0.348 €.

      Valerio Therapeutics currently has 154,364,273 shares outstanding. The market capitalization of Valerio Therapeutics is 15.28 € million. Valerio Therapeutics has a price to earnings ratio (PE ratio) of -9.71.

      ALVIO Latest News

      More News

      Valerio Therapeutics : compte rendu de l’assemblée générale mixte du 4 juin 2024

      Regulatory News: Valerio Therapeutics S.A. (Euronext Growth Paris : ALVIO), ci-après « Valerio Therapeutics » ou « la Société », société de biotechnologie au stade clinique spécialisée dans le...

      June 05 2024
      Business Wire

      Valerio Therapeutics Provides Clinical Development Update on Its Phase 1/2 VIO-01 Clinical Trial

      The first dose level, evaluating 3 patients of the VIO-01-101 trial has been cleared as per the recommendations of the Clinical Review Committee. No clinically significant adverse events or...

      May 22 2024
      Business Wire

      Valerio Therapeutics Reports Full Year 2023 Financial Results and Provides Clinical Development Updates

      Cash position of €6.8 million as of December 31, 2023 Financial visibility until the end of fourth quarter of 2024 Regulatory News: Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO...

      April 30 2024
      Business Wire

      Valerio Therapeutics Announces a Capital Reduction Motivated by Losses by Reducing the Nominal Value of the Company's Shares

      Regulatory News: Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO), hereafter “Valerio Therapeutics” or the “Company”, a clinical-stage biotechnology company specializing in the...

      February 06 2024
      Business Wire

      Half-Year Liquidity Contract Statement for Valerio Therapeutics

      Regulatory News: Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO) Under the liquidity contract entered into between Valerio Therapeutics and Kepler Cheuvreux, the following resources...

      January 31 2024
      Business Wire

      Valerio Therapeutics Reports its Half-Year 2023 Financial Results and Provides an Update on its Activities

      New identity unveiled, with the aim at developing innovative therapies against cancer R&D efforts maintained for VIO-01 (formerly OX425) and AsiDNATM Optimization of PlatONTM platform...

      September 28 2023
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.0004-0.3984063745020.10040.10480.099443640.10019335DE
      4-0.002-1.960784313730.1020.10540.099499690.10156184DE
      12-0.016-13.79310344830.1160.1240.099726860.10716035DE
      26-0.0345-25.65055762080.13450.14250.09856140.11475764DE
      52-0.14-58.33333333330.240.3480.09845310.17556025DE
      156-0.173-63.369963370.2730.3480.09801490.17907231DE
      260-0.173-63.369963370.2730.3480.09801490.17907231DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      SERVServe Robotics Inc
      $ 7.51
      (185.55%)
      		266.26M
      AUGXAugmedix Inc
      $ 2.27
      (147.71%)
      		24.14M
      XCURExicure Inc
      $ 0.5351
      (76.02%)
      		14.02M
      PSNLPersonalis Inc
      $ 3.83
      (56.33%)
      		22.8M
      MDBHMDB Capital Holdings LLC
      $ 10.675
      (37.21%)
      		126.45k
      SPWRSunPower Corporation
      $ 0.6735
      (-55.40%)
      		124.61M
      HYZNHyzon Motors Inc
      $ 0.149
      (-47.54%)
      		23.63M
      MEDSTRxADE Health Inc
      $ 14.92
      (-33.45%)
      		223.27k
      SILOSilo Pharma Inc
      $ 2.50
      (-27.95%)
      		11.93M
      KITTNauticus Robotics Inc
      $ 0.0935
      (-27.46%)
      		28.43M
      SERVServe Robotics Inc
      $ 7.51
      (185.55%)
      		262.73M
      NVDANVIDIA Corporation
      $ 117.93
      (-2.61%)
      		206.41M
      SXTP60 Degrees Pharmaceuticals Inc
      $ 0.2602
      (5.77%)
      		202.14M
      SQQQProShares UltraPro Short QQQ
      $ 8.46
      (2.79%)
      		184.21M
      SPWRSunPower Corporation
      $ 0.6735
      (-55.40%)
      		119.98M

      Discussion

      View Full Feed
      Bull_Dolphin Bull_Dolphin 5 minutes ago
      Once again, WOW. Thanks for this longer version!
      How can this be argued against?
      Oh that's right, we only trust the science when it agrees with the narrative.
      misterfishman misterfishman 6 minutes ago
      True that.
      IGPK
      MightyX MightyX 9 minutes ago
      All these shares-traded past-weeks were trader-group-fraud alongside their slander/libel.
      TPTW
      MightyX MightyX 11 minutes ago
      More to follow
      TPTW
      MightyX MightyX 12 minutes ago
      Restricted OS increased significantly over 2B..not retail
      TPTW
      Juntao Juntao 12 minutes ago
      DNAX .0002 https://www.otcmarkets.com/stock/DNAX/security
      DNAX
      MightyX MightyX 13 minutes ago
      Trader groups getting passed up for new shares.
      TPTW
      Truth_is_a_tool Truth_is_a_tool 18 minutes ago
      “I have been waiting for fourteen years.”

      omg You’ve been invested in this penny stock , Kblb, for 14 years, just waiting for a ROI ?! Man , I would NOT be bragging about that lol Do you realize how much money you’ve probably lost over the years by having your money tied up here in
      KBLB
      Nesurk Nesurk 20 minutes ago
      Hi 4retire, I am still here. I hope all is well with you. Seems like a lifetime ago that I first bought my initial shares back in the late nineties. I have added through the years, decades....lol.

      I am just waiting for the TMMI movie to come out...lol
      TMMI
      ALDRADJKD123 ALDRADJKD123 21 minutes ago
      Things just aren’t adding up,

      https://youtu.be/rXQBIr96vyU?si=nvsPS6QXWinm07mo

      And remember, there was a large short position taken out before the assassination attempt.
      SkeBallLarry SkeBallLarry 26 minutes ago
      Bob Baffert Churchill Downs suspension lifted after 3 years.
      reindlll reindlll 28 minutes ago
      Double posz
      IGEN
      reindlll reindlll 28 minutes ago
      Question or fact?
      IGEN
      floridaboy floridaboy 29 minutes ago
      Good to see another filing...
      MEDH
      Iggy_Bot Iggy_Bot 32 minutes ago
      GM, y/w, I didn't even know she was sick..
      Diamondhands45 Diamondhands45 34 minutes ago
      Add to longs or shorts moon? Thank you so much for all the TA
      TSLA
      rocketeer357 rocketeer357 36 minutes ago
      Mets need to learn to count to 7. 6 ain't enough.
      dennisdave dennisdave 37 minutes ago
      You know this isn’t just about L, it’s about the platform set up what platform? There has been platform talk for years now without NWBO conducting any active new DCVAX medical trial. This platform talk is a big BS without NWBO pursuing any DCVAX medical trial. That is because NWBO is too busy invest
      NWBO
      Nemesis18 Nemesis18 45 minutes ago
      I 100% agree with you, as from the moment I was given that diagnosis by the Kings' Neuro-Oncological Clinical Trial Nurse, I too doubted it.

      It was a clear error, which to this day, they have been unwilling to own and make good for
      NWBO
      SkeBallLarry SkeBallLarry 47 minutes ago
      " Thank you, Iggy ~ just saw that & Good Morning " .. !!
      Moonboy1 Moonboy1 53 minutes ago
      What I don't understand is how us it legal to do a share offering under $1.00 at .80 when you have to be over $1 to be compliant with the Nasdaq. Makes zero sense to me
      BOF
      No-Quarter No-Quarter 56 minutes ago
      Yup, your chart makes it easy to see when the toilet flushed.

      https://youtu.be/kK-2E4MTc3Y?si=JF_nixHzOh1X1AlB
      appie appie 57 minutes ago
      If you google devon orthopedics exlite holdings you see Trellis Law. Case devon orthopedics vs exlites holdings filed june 23 2023 latest update june 07 2024 GEGP$$$$
      GEGP
      JOoa0ky JOoa0ky 57 minutes ago
      I'm having trouble deciding who has the wildest fantasies.

      Wiseman or Melonbun?
      FNMA

      Your Recent History

      EU
      ALVIO
      Valerio Therapeutics
      Delayed Upgrade Clock